Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Oncogene
|
December 21, 2019
Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration
Carolyn J Loveridge, Sarah Slater, Kirsteen J Campbell, et al.
BMC Rheumatology
|
July 19, 2021
BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort study
Fiona Rayner, Amy E Anderson, Kenneth F Baker, et al.
Annals of the Rheumatic Diseases
|
October 18, 2025
Spatial profiling of giant cell arteritis tissues reveals immune heterogeneity and potential predictors of glucocorticoid response
Cecilia Ansalone, Samuel McAllister, Ethan S Pickerill, et al.
Therapeutic Advances in Musculoskeletal Disease
|
September 11, 2023
Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis
Oliver FitzGerald, Frank Behrens, Anne Barton, et al.
Nature Reviews. Rheumatology
|
January 25, 2018
Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaboration
Andrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Nature Reviews. Rheumatology
|
December 8, 2017
The RA-MAP Consortium: a working model for academia-industry collaboration
Andrew P Cope, Michael R Barnes, Alexandra Belson, et al.
British Journal of Haematology
|
November 17, 2024
Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients
Hayley Colton, Natalie Barratt, Nigel Temperton, et al.
Nature Medicine
|
July 6, 2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Eleanor Barnes, Carl S Goodyear, Michelle Willicombe, et al.
The Lancet. Rheumatology
|
May 11, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial
Carl S Goodyear, Amit Patel, Eleanor Barnes, et al.
European Journal of Immunology
|
October 13, 2017
Guidelines for the use of flow cytometry and cell sorting in immunological studies
Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Oncogene
|
December 21, 2019
Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration
Carolyn J Loveridge, Sarah Slater, Kirsteen J Campbell, et al.
BMC Rheumatology
|
July 19, 2021
BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort study
Fiona Rayner, Amy E Anderson, Kenneth F Baker, et al.
Annals of the Rheumatic Diseases
|
October 18, 2025
Spatial profiling of giant cell arteritis tissues reveals immune heterogeneity and potential predictors of glucocorticoid response
Cecilia Ansalone, Samuel McAllister, Ethan S Pickerill, et al.
Therapeutic Advances in Musculoskeletal Disease
|
September 11, 2023
Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis
Oliver FitzGerald, Frank Behrens, Anne Barton, et al.
Nature Reviews. Rheumatology
|
January 25, 2018
Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaboration
Andrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Nature Reviews. Rheumatology
|
December 8, 2017
The RA-MAP Consortium: a working model for academia-industry collaboration
Andrew P Cope, Michael R Barnes, Alexandra Belson, et al.
British Journal of Haematology
|
November 17, 2024
Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients
Hayley Colton, Natalie Barratt, Nigel Temperton, et al.
Nature Medicine
|
July 6, 2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Eleanor Barnes, Carl S Goodyear, Michelle Willicombe, et al.
The Lancet. Rheumatology
|
May 11, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial
Carl S Goodyear, Amit Patel, Eleanor Barnes, et al.
European Journal of Immunology
|
October 13, 2017
Guidelines for the use of flow cytometry and cell sorting in immunological studies
Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
Page
of 10